The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Androgen Receptor Full-length Specific assay is a sandwich immunoassay for quantitative detection of androgen receptor full-length specific in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Androgen Receptor Full-length Specific assay is a sandwich immunoassay for quantitative detection of androgen receptor full-length specific in cellular lysates using Alpha Technology.
Loading...
The full-length androgen receptor (AR-FL) represents the canonical, ligand-dependent form of AR comprising all functional domains: the N-terminal transactivation domain (NTD), DNA-binding domain (DBD), hinge region, and C-terminal ligand-binding domain (LBD). AR-FL requires androgen binding to the LBD for full activation, nuclear translocation, and transcriptional activity, making it the primary target of androgen deprivation therapies and second-generation antiandrogens such as enzalutamide and apalutamide, which competitively inhibit ligand binding. In castration-resistant prostate cancer (CRPC), AR-FL can be aberrantly activated through AR gene amplification, LBD point mutations that broaden ligand specificity, or intratumoral androgen synthesis. AR-FL-specific detection, which distinguishes full-length AR from truncated splice variants lacking the LBD, is essential for accurately characterizing AR signaling status and predicting response to LBD-targeting therapies. Monitoring AR-FL levels in the context of emerging splice variants provides critical insight into mechanisms of therapeutic resistance in prostate cancer.
The AlphaLISA SureFire Biotin-Free Human and Mouse Androgen Receptor Full-length Specific Detection Kit is a sandwich immunoassay for the quantitative detection of androgen receptor full-length in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
LNCaP cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 PROTAC for 18 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Lysates were further diluted and AR-FL and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays*. For the detection step, 10 µL of cell lysate (approximately 1,200 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, ARV-110 induced a dose dependent decrease in AR-FL with no significant changes ERK Total levels.
*AR-FL Specific assay only recognizes Full Length AR protein.
MCF7 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 PROTAC for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR-FL and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, ARV-110 induced a dose dependent decrease in AR-FL with no significant changes in the levels of ERK Total.
22Rv1 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of AR Degrader-8 for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Lysates were further diluted and AR-FL and ERK Total levels were evaluated using AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 1,200 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, AR Degrader-8 induced a dose-dependent decrease in AR-FL with no change in ERK Total levels.
Adherent cells were grown to confluency in a T175 flask in complete medium and lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 1.6 x 106 cells/mL.
AR-FL levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (5,000 adherent and 16,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
AR-FL expression was detected in various cell lines. Elevated levels were observed in LNCaP cells. No expression was detected in PC3 cells (AR negative cell line).
Cell lysate was prepared from LNCaP cells seeded in T175 flasks and cultured to confluence and lysed in 8 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and AR-FL levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The AR-FL Specific Total assay can detect AR-FL expression in less than 100 cells.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
Androgen
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
10,000 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Loading...
We are here to answer your questions.